Form D · Biotechnology
ALPINE IMMUNE SCIENCES, INC.
Seattle, WA · CIK 0001626199
Offering snapshot reported Sep 29, 2021 · SEC filing
- Reported sold
- $91M Offering amount: $91M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 17, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2021 | Initial | $90,999,934 | No comparison | 16 | SEC filing |
| Aug 7, 2020 | Initial | $60,000,013 | No comparison | 25 | SEC filing |
| Jan 30, 2019 | Initial | $25,274,979 | No comparison | 8 | SEC filing |
| Nov 25, 2014 | Initial | $30,000,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-415077
The Issuer issued and sold 6,489,357 shares and 3,191,487 prefunded warrants to purchase shares at an exercise price of $0.001 per share. The purchase price of the shares and the prefunded warrants was $9.40 per security.
Source: Form D, filed Sep 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Conway | Director |
| Howard Furst | Director |
| Mitchell Gold | Director, Executive |
| Zelanna Goldberg | Executive |
| Natasha Hernday | Director |
| Jonathan Leff | Director |
| Mark James Litton | Executive |
| Evan Loh | Director |
| Joseph Loscalzo | Director |
| John Moore | Director |
| Christopher Peetz | Director |
| Stanford Peng | Executive |
| James Paul Rickey | Executive |
| Paul Sekhri | Director |
| Tom Sokolowski | Executive |
| Peter Thompson | Director |
| James Topper | Director |
| Jay Venkatesan | Director |
| Cui Xiangmin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
188 East Blaine St., Suite 200
Seattle, WA, 98102
Seattle, WA, 98102